The Hepatitis C Transplant Collaborative

Part of paid clinical trials in Dallas, Texas.

Sponsor
Baylor Research Institute
Study ID
NCT04493385
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.

Key Dates

First listed
Jul 30, 2020
Start date
Sep 16, 2019
Status verified
Jan 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Number of donor HCV nucleic-acid testing positive (HCV NAT+) cardiac transplantation [ Time Frame: 6.5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Baylor Scott & White Health Research InstituteDallasTexas75246
Joost Felius, PhD
[email protected]
214-818-8943

Find similar trials in Dallas, TX

By research site
Baylor Scott & White Health Research Institute· Dallas, TX

Related Studies